1. No calcitonin change in a person taking dulaglutide diagnosed with pre‐existing medullary thyroid cancer. Issue 3 (13th February 2018) Authors: Sherman, S. I.; Kloos, R. T.; Tuttle, R. M.; Pontecorvi, A.; Völzke, H.; Harper, K.; Vance, C.; Alston, J. T.; Usborne, A. L.; Sloop, K. W.; Lakshmanan, M. Journal: Diabetic medicine Issue: Volume 35:Issue 3(2018) Page Start: 381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗